USANA Health Sciences USNA China — Net Sales
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by USANA Health Sciences in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: USANA Health Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about USANA Health Sciences's china — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is USANA Health Sciences's china — net sales?
- USANA Health Sciences (USNA) reported china — net sales of $112.51M in Q1 2026.
- How has USANA Health Sciences's china — net sales changed year-over-year?
- USANA Health Sciences's china — net sales increased by 4.5% year-over-year, from $107.69M to $112.51M.
- What is the long-term trend for USANA Health Sciences's china — net sales?
- Over 4 years (2021 to 2025), USANA Health Sciences's china — net sales has grown at a -6.8% compound annual growth rate (CAGR), from $506.1M to $381.82M.
- What does china — net sales mean?
- This metric represents the total revenue generated from the sale of nutritional and personal-care products within the China geographic segment. It reflects the company's market penetration and consumer demand in this specific region through its direct selling business model. Monitoring this figure helps investors assess the segment's contribution to overall corporate growth and its sensitivity to regional economic or regulatory shifts.